To study the effects of a Unani formulation in patients with Psoriasis
Phase 2
- Conditions
- Health Condition 1: L400- Psoriasis vulgaris
- Registration Number
- CTRI/2023/03/050383
- Lead Sponsor
- Central Council for Research in Unani Medicine New Delhi
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- ot Yet Recruiting
- Sex
- Not specified
- Target Recruitment
- 0
Inclusion Criteria
1. Clinically diagnosed patients of psoriasis.
2. Patients of both genders.
3. Patients in the age group of 10-60 years.
4. Clinically stable patients.
Exclusion Criteria
1. Childrens below 10 years.
2. Patients above 60 years.
3. Pregnant and lactating females.
4. Patients suffering from other concomitant diseases like dermatophytes, eczema, seborrheic dermatitis, Pityriasis Rosea.
5. Patients suffering from diabetes and malignancy.
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method 1. Koebner phenomenon. <br/ ><br>2. Ring of worn off. <br/ ><br>3. Candle grease sign. <br/ ><br>4. Oil drop sign. <br/ ><br>5. KOH examination of skin scrap <br/ ><br>6. Auzpitz sign. <br/ ><br>7. Interleukin 17 and Interleukin 23. <br/ ><br>8. Psoriasis Area Severity Index (PASI). <br/ ><br>9. Dermatology Life Quality Index (DLQI) <br/ ><br>10. Photos of lesion (Before and After)Timepoint: 90 Days
- Secondary Outcome Measures
Name Time Method 1. Erythematous plaques. <br/ ><br>2. Silvery scaling lesions. <br/ ><br>3. Itching. <br/ ><br>4. Visual Analog Scale (VAS). <br/ ><br>Timepoint: 90 Days